Selected research
Market Structure
Global Artesunate Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Artesunate Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Artesunate Medicines include Shin Poong, Sanofi Aventis, MCW Healthcare, Ipca Laboratories, Fosun Pharma (Guilin), Cipla, Ajanta Pharma and Acino, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Artesunate Medicines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artesunate Medicines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artesunate Medicines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Artesunate Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.
Artesunate Medicines Segment by Company
Shin Poong
Sanofi Aventis
MCW Healthcare
Ipca Laboratories
Fosun Pharma (Guilin)
Cipla
Ajanta Pharma
Acino
Artesunate Medicines Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Artesunate Medicines Segment by Application
Hospital
Clinic
Other
Artesunate Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artesunate Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Artesunate Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artesunate Medicines industry.
Chapter 3: Detailed analysis of Artesunate Medicines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artesunate Medicinesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoaromatic Artesunate
- Compound Artesunate
Applications
- Hospital
- Clinic
- Other
Companies covered
- Shin Poong
- Sanofi Aventis
- MCW Healthcare
- Ipca Laboratories
- Fosun Pharma (Guilin)
- Cipla
- Ajanta Pharma
- Acino
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Artesunate Medicines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Monoaromatic Artesunate
- 1.2.3 Compound Artesunate
- 1.3 Market Analysis by Application
- 1.3.1 Global Artesunate Medicines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Artesunate Medicines Growth Trends by Region
- 1.5.1 Global Artesunate Medicines Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Artesunate Medicines Market Size by Region (2021-2026)
- 1.5.3 Artesunate Medicines Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Artesunate Medicines Market Dynamics
- 2.1 Artesunate Medicines Industry Trends
- 2.2 Artesunate Medicines Industry Drivers
- 2.3 Artesunate Medicines Industry Opportunities and Challenges
- 2.4 Artesunate Medicines Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Artesunate Medicines Revenue by Company (2021-2026)
- 3.2 Global Artesunate Medicines Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Artesunate Medicines Key Company Head office and Area Served
- 3.4 Global Artesunate Medicines Company, Product Type & Application
- 3.5 Global Artesunate Medicines Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Artesunate Medicines Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Artesunate Medicines Players Market Share by Revenue in 2025
- 3.6.3 2025 Artesunate Medicines Tier 1, Tier 2, and Tier 3
4 Artesunate Medicines Market by Type
- 4.1 Global Artesunate Medicines Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Artesunate Medicines Market Size by Type (2021-2032)
- 4.3 Global Artesunate Medicines Market Size Share by Type (2021-2032)
5 Artesunate Medicines Market by Application
- 5.1 Global Artesunate Medicines Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Artesunate Medicines Market Size by Application (2021-2032)
- 5.3 Global Artesunate Medicines Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Shin Poong
- 6.1.1 Shin Poong Company Information
- 6.1.2 Shin Poong Business Overview
- 6.1.3 Shin Poong Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Shin Poong Artesunate Medicines Product Portfolio
- 6.1.5 Shin Poong Recent Developments
- 6.2 Sanofi Aventis
- 6.2.1 Sanofi Aventis Company Information
- 6.2.2 Sanofi Aventis Business Overview
- 6.2.3 Sanofi Aventis Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sanofi Aventis Artesunate Medicines Product Portfolio
- 6.2.5 Sanofi Aventis Recent Developments
- 6.3 MCW Healthcare
- 6.3.1 MCW Healthcare Company Information
- 6.3.2 MCW Healthcare Business Overview
- 6.3.3 MCW Healthcare Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 MCW Healthcare Artesunate Medicines Product Portfolio
- 6.3.5 MCW Healthcare Recent Developments
- 6.4 Ipca Laboratories
- 6.4.1 Ipca Laboratories Company Information
- 6.4.2 Ipca Laboratories Business Overview
- 6.4.3 Ipca Laboratories Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Ipca Laboratories Artesunate Medicines Product Portfolio
- 6.4.5 Ipca Laboratories Recent Developments
- 6.5 Fosun Pharma (Guilin)
- 6.5.1 Fosun Pharma (Guilin) Company Information
- 6.5.2 Fosun Pharma (Guilin) Business Overview
- 6.5.3 Fosun Pharma (Guilin) Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio
- 6.5.5 Fosun Pharma (Guilin) Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Cipla Artesunate Medicines Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Ajanta Pharma
- 6.7.1 Ajanta Pharma Company Information
- 6.7.2 Ajanta Pharma Business Overview
- 6.7.3 Ajanta Pharma Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Ajanta Pharma Artesunate Medicines Product Portfolio
- 6.7.5 Ajanta Pharma Recent Developments
- 6.8 Acino
- 6.8.1 Acino Company Information
- 6.8.2 Acino Business Overview
- 6.8.3 Acino Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Acino Artesunate Medicines Product Portfolio
- 6.8.5 Acino Recent Developments
7 North America
- 7.1 North America Artesunate Medicines Market Size (2021-2032)
- 7.2 North America Artesunate Medicines Market Size by Type
- 7.2.1 North America Artesunate Medicines Market Size by Type (2021-2026)
- 7.2.2 North America Artesunate Medicines Market Size by Type (2027-2032)
- 7.2.3 North America Artesunate Medicines Market Share by Type (2021-2032)
- 7.3 North America Artesunate Medicines Market Size by Application
- 7.3.1 North America Artesunate Medicines Market Size by Application (2021-2026)
- 7.3.2 North America Artesunate Medicines Market Size by Application (2027-2032)
- 7.3.3 North America Artesunate Medicines Market Share by Application (2021-2032)
- 7.4 North America Artesunate Medicines Market Size by Country
- 7.4.1 North America Artesunate Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Artesunate Medicines Market Size by Country (2021-2026)
- 7.4.3 North America Artesunate Medicines Market Size by Country (2027-2032)
- 7.4.4 North America Artesunate Medicines Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Artesunate Medicines Market Size (2021-2032)
- 8.2 Europe Artesunate Medicines Market Size by Type
- 8.2.1 Europe Artesunate Medicines Market Size by Type (2021-2026)
- 8.2.2 Europe Artesunate Medicines Market Size by Type (2027-2032)
- 8.2.3 Europe Artesunate Medicines Market Share by Type (2021-2032)
- 8.3 Europe Artesunate Medicines Market Size by Application
- 8.3.1 Europe Artesunate Medicines Market Size by Application (2021-2026)
- 8.3.2 Europe Artesunate Medicines Market Size by Application (2027-2032)
- 8.3.3 Europe Artesunate Medicines Market Share by Application (2021-2032)
- 8.4 Europe Artesunate Medicines Market Size by Country
- 8.4.1 Europe Artesunate Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Artesunate Medicines Market Size by Country (2021-2026)
- 8.4.3 Europe Artesunate Medicines Market Size by Country (2027-2032)
- 8.4.4 Europe Artesunate Medicines Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Artesunate Medicines Market Size (2021-2032)
- 9.2 China Artesunate Medicines Market Size by Type
- 9.2.1 China Artesunate Medicines Market Size by Type (2021-2026)
- 9.2.2 China Artesunate Medicines Market Size by Type (2027-2032)
- 9.2.3 China Artesunate Medicines Market Share by Type (2021-2032)
- 9.3 China Artesunate Medicines Market Size by Application
- 9.3.1 China Artesunate Medicines Market Size by Application (2021-2026)
- 9.3.2 China Artesunate Medicines Market Size by Application (2027-2032)
- 9.3.3 China Artesunate Medicines Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Artesunate Medicines Market Size (2021-2032)
- 10.2 Asia Artesunate Medicines Market Size by Type
- 10.2.1 Asia Artesunate Medicines Market Size by Type (2021-2026)
- 10.2.2 Asia Artesunate Medicines Market Size by Type (2027-2032)
- 10.2.3 Asia Artesunate Medicines Market Share by Type (2021-2032)
- 10.3 Asia Artesunate Medicines Market Size by Application
- 10.3.1 Asia Artesunate Medicines Market Size by Application (2021-2026)
- 10.3.2 Asia Artesunate Medicines Market Size by Application (2027-2032)
- 10.3.3 Asia Artesunate Medicines Market Share by Application (2021-2032)
- 10.4 Asia Artesunate Medicines Market Size by Country
- 10.4.1 Asia Artesunate Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Artesunate Medicines Market Size by Country (2021-2026)
- 10.4.3 Asia Artesunate Medicines Market Size by Country (2027-2032)
- 10.4.4 Asia Artesunate Medicines Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Artesunate Medicines Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Artesunate Medicines Market Size by Type
- 11.2.1 South America, Middle East & Africa Artesunate Medicines Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Artesunate Medicines Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Artesunate Medicines Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Artesunate Medicines Market Size by Application
- 11.3.1 South America, Middle East & Africa Artesunate Medicines Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Artesunate Medicines Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Artesunate Medicines Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Artesunate Medicines Market Size by Country
- 11.4.1 South America, Middle East & Africa Artesunate Medicines Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Artesunate Medicines Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Artesunate Medicines Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Artesunate Medicines Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst